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Summary
 
To investigate the potential involvement of T helper (Th)2-type responses in murine models of
intestinal inflammation, we used trinitrobenzene sulfonic acid (TNBS)–hapten to induce in-
 
flammatory bowel disease in situations where Th1-type responses with interferon (IFN)-
 
g
 
 syn-
thesis are either diminished or do not occur. Intracolonic administration of TNBS to either
 
normal (IFN-
 
g
 
1
 
/
 
1
 
) or Th1-deficient IFN-
 
g
 
 knockout (IFN-
 
g
 
2
 
/
 
2
 
) BALB/c mice resulted in
significant colitis. In IFN-
 
g
 
2
 
/
 
2
 
 mice, crypt inflammation was more severe than in IFN-
 
g
 
1
 
/
 
1
 
mice and was accompanied by hypertrophy of colonic patches with a lymphoepithelium con-
taining M cells and distinct B and T cell zones resembling Peyer’s patches. Hapten-specific, co-
 
lonic patch T cells from both mouse groups exhibited a Th2 phenotype with interleukin (IL)-4
 
and IL-5 production. TNBS colitis in normal mice treated with anti–IL-4 antibodies or in IL-4
 
2
 
/
 
2
 
mice was less severe than in either IFN-
 
g
 
1
 
/
 
1
 
 or IFN-
 
g
 
2
 
/
 
2
 
 mice. Our findings now show that
the Th2-type responses in TNBS colitis are associated with colonic patch enlargement and in-
flammation of the mucosal layer and may represent a model for ulcerative colitis.
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T
 
he normal mucosal immune system in the gastrointes-
tinal tract maintains a delicate balance between immu-
nity to microbial pathogens and tolerance to food antigens
and indigenous microflora. Despite its importance in pro-
tecting against disease and maintaining homeostasis, mu-
 
cosal immunity is only partially understood. What is clear
is that the mucosal immune system can be divided into in-
ductive sites and effector regions. The former are termed
gut-associated lymphoreticular tissues (GALT)
 
1 
 
and include
Peyer’s patches, whereas the latter is a lamina propria char-
acterized by more diffuse collections of lymphocytes and
plasma cells. Active induction of selected immune responses
in the GALT has been shown to lead to either upregulation
of antipathogenic responses or to actual suppression of sys-
temic immunity to ubiquitous oral antigens.
Inflammatory bowel diseases (IBD) represent chronic, re-
lapsing, and tissue-destructive diseases. Although the etiology
of IBD remains unknown, there is circumstantial evidence
to link IBD to the mucosal immune system’s failure to at-
tenuate immunity to luminal antigens (1, 2). A recent study
has shown a primary role for T cells in IBD by demonstrat-
ing that anti-CD4 monoclonal antibodies are effective in
treating the disease (3). Various experimental murine models
of IBD also support a central role for T cells in chronic intes-
tinal inflammation (4–8). These models were characterized
by an imbalance of regulatory cytokines, most notably by an
 
excessive production of IFN-
 
g
 
. A central role for IFN-
 
g
 
has been reported in murine colitis following transfer of
 
CD45RB
 
high
 
 T cells to 
 
scid
 
 mice (4, 9, 10), by adoptive
transfer of T cell–depleted bone marrow cells from normal
 
mice into T cell–deficient CD3
 
e
 
-transgenic mice (11), and
 
in IL-10
 
2
 
/
 
2
 
 mice, which spontaneously develop a severe fo-
cal inflammation in both the small and large intestines (12).
Another important mouse model has been introduced to
study specific T cell subsets in the intestinal inflammation
resulting from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-
induced colitis, a system first established in rats (13). The
colonic administration of TNBS in 50% ethanol has been
shown to induce a chronic colitis (14, 15) as a result of co-
valent binding of TNP residues to autologous host proteins
with subsequent stimulation of delayed-type hypersensitiv-
ity to the TNP-modified self antigens (16). Previous studies
using SJL/J mice have emphasized that Th1-type responses
with production of IL-2 and IFN-
 
g
 
 are associated with this
 
1
 
Abbreviations used in this paper:
 
 GALT, gut-associated lymphoreticular tis-
sues; IBD, inflammatory bowel diseases; PNA, peanut agglutinin; SLN,
sacral lymph nodes; TNBS, 2,4,6-trinitrobenzene sulfonic acid. 
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TNBS-induced Colitis in IFN-
 
g
 
–deficient Mice
 
induced colitis, and treatment with anti–IL-12 antibody mark-
edly decreased the severity of TNBS-induced colitis (14, 17).
Thus, most mouse IBD models are associated with acti-
vated T cells producing cytokines characteristic of a Th1
phenotype, a finding in agreement with clinical observa-
tions of Crohn’s disease (18–20). However, as the produc-
tion of Th1-type cytokines is not as pronounced in ulcer-
ative colitis as in Crohn’s disease (21, 22), we hypothesized
that a Th2-type response is also operative in the ulcerative
colitis type of chronic intestinal inflammation. In this study,
we examined the development of TNBS-induced inflam-
mation in cytokine-deficient mice to determine whether
the colitis that develops could be associated with a Th2-
type cytokine array. Our results provide the first evidence
that Th2-type responses are predominant in TNBS colitis
in BALB/c mice and that the resultant disease is character-
ized by hypertrophy of colonic patches. Furthermore, we
show that mice undergoing Th2-type responses develop a
disease that more closely resembles ulcerative colitis than
Crohn’s disease.
 
Materials and Methods
 
Mice.
 
Normal (IFN-
 
g
 
1
 
/
 
1
 
), IFN-
 
g
 
 gene–disrupted (IFN-
 
g
 
2
 
/
 
2
 
),
and IL-4 gene–disrupted (IL-4
 
2
 
/
 
2
 
) mice, all on the BALB/c
background, were purchased from The Jackson Laboratory. Mice
were kept in microisolator cages in animal facilities at The Uni-
versity of Alabama at Birmingham Immunobiology Vaccine
Center. Mice were provided sterile food and water ad libitum
and were free of microbial pathogens as determined by antibody
screening and routine histologic analysis of organs and tissues. All
mice used in this study were between 10 and 16 wk of age.
 
Hapten-induced Colitis.
 
Mice were given a solution of TNBS
(Research Organics) dissolved in a mixture of PBS, pH 7.2, and
then mixed with an equal volume of ethanol for a final concen-
tration of 2% TNBS in 50% ethanol. Enemas were performed on
mice anesthetized with ketamine/xylazine with a glass microsy-
ringe equipped with a gastric intubation needle. One series of ex-
periments was performed to compare the sensitivity of IFN-
 
g
 
1
 
/
 
1
 
or IFN-
 
g
 
2
 
/
 
2 
 
mice to TNBS colitis. In brief, groups of mice were
given TNBS at a dose of 25, 36, or 50 
 
m
 
g/g of body weight on
days 0 and 7. The severity of disease was assessed by weight loss,
fur ruffling, rectal prolapse, and death. A dose of 36 
 
m
 
g TNBS/g
of body weight was chosen and given on days 0 and 7, and tissues
and cells were assessed on day 10.
 
Treatment with Monoclonal Anticytokine Antibodies.
 
One set of
experiments was performed with mAbs to IFN-
 
g
 
 or IL-4 to deter-
mine the roles of these cytokines in the development of TNBS
colitis. In brief, mice were given 1 mg of either rat anti–IFN-
 
g
 
(XMG 1.2) or anti–IL-4 (11B11) mAbs by the intraperitoneal
route on the same days as the TNBS enema (days 0 and 7). Control
groups received an intraperitoneal dose of normal rat IgG (Jackson
ImmunoResearch Labs, Inc.) along with a TNBS enema.
 
Histological Analysis.
 
The colon was removed from its mesen-
tery to the pelvic brim by blunt dissection. The pelvis was sev-
ered, and the rectum was carefully removed from the sacral
lymph nodes (SLN) and adjacent tissue. The distal half of the co-
lon was opened longitudinally and fixed in 5% glacial acetic acid
in ethanol (vol/vol). After embedding in paraffin, 4-
 
m
 
m-thick se-
rial sections were prepared and stained with hematoxylin and
eosin for histologic grading. Thickness of lymphoid follicles was
determined on sections that contained follicles extending from
the mucosal layer to the serosa using a micrometer. Histologic
grading was done blindly according to the criteria listed in Ta-
ble I. A maximum score of 8 indicated severe colitis with acute
ulcers and an overall diffuse pattern of chronic changes.
 
Immunohistochemistry.
 
Tissues were freshly frozen in Tissue-
Tec OCT compound (Miles-Yeda, Inc.). 7-
 
m
 
m cryostat sections
were fixed in ice-cold acetone for 10 min, dried, and rehydrated
in Tris-buffered saline. This step was followed by blocking with
Tris-buffered saline containing a 1:50 dilution of Fc-blocking
2.4G2 mAb (PharMingen) and 10% heat-aggregated rabbit serum
(Sigma Chemical Co.). Sections were stained for 1 h in the same
buffer with PE–anti-CD4 mAb (1:50 dilution; PharMingen) and
biotinylated anti-B220 mAb (1:50 dilution; PharMingen). These
sections were washed with buffer and then stained with streptavi-
din–FITC (Southern Biotechnology Associates) for 30 min. Reac-
tivity with peanut agglutinin (PNA) was demonstrated using a 1:50
dilution of biotinylated PNA (Vector Labs, Inc.) and streptavi-
din–FITC. The sections were mounted and viewed using 100
 
3
 
optics and a dual red/green filter. Images from each staining were
analyzed for red and green fluorescence using identical settings in
Photoshop 4.0 (Adobe Systems, Inc.).
 
Electron Microscopy.
 
For transmission electron microscopy, the
colon was prefixed with cold 2% glutaraldehyde in 0.1 M phos-
phate buffer, pH 7.4, for 2 h and washed extensively with 0.1 M
phosphate buffer. The tissues were then post-fixed with osmium
tetraoxide, dehydrated, and embedded in Epon. Sections were
cut and examined with an electron microscope.
 
Preparation of Lymphoid Cells from Tissues.
 
Peyer’s, cecal, and
colonic patches were excised from the intestinal wall. The colonic
lymphoid follicles in naive mice were identified with a magnifying
 
Table I.
 
Histological Scoring System Used in TNBS-induced Colitis
 
Histological changes
Scores
01 2
Crypt distortion None Focal Numerous or diffuse
Crypt with loss of goblet cells None A few crypts Many crypts
Acute inflammation (ulcers with infiltration of
polymorphonuclear cells) None Superficial Beyond the layer of 
 
Muscularis mucosae
 
Chronic inflammation (infiltration of mononuclear
cells and fibrosis in the mucosal layer) No increase Focal Multifocal 
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lens, and 
 
z
 
3–5 follicles/colon were seen. Patches and follicles
were washed once with RPMI 1640 (Cellgro Mediatech) and
dissociated with collagenase (type IV; Sigma Chemical Co.) at a
concentration of 0.5 mg/ml in RPMI 1640 with 100 U/ml pen-
icillin, 100 
 
m
 
g/ml streptomycin, and 40 
 
m
 
g/ml gentamicin for 20
min at 37
 
8
 
C to obtain single-cell preparations (23). The cell dis-
sociation was repeated two additional times in fresh collagenase
solution each time. The single-cell suspensions were then pooled
and washed with RPMI 1640 twice more. Mononuclear cells
were further purified using a discontinuous Percoll gradient to
avoid contamination with epithelial cells. The SLN were teased
with forceps, and the resulting cell suspension was washed with
RPMI 1640 two additional times. Colonic lamina propria lym-
phocytes were prepared as previously described with modifica-
tions (24). In brief, after excision of all visible lymphoid follicles,
colonic tissue was treated with 1 mM EDTA in PBS for 20 min
to remove the epithelium. The tissue was then digested with col-
lagenase (type IV; Sigma Chemical Co.) for 20 min, and this step
was repeated two more times. The isolated cells were further
purified and separated from epithelial cells by centrifugation
through a Percoll gradient as described elsewhere (24). The iso-
lated lamina propria lymphocytes were 
 
.
 
99% viable.
 
Flow Cytometry and Cell Sorting.
 
In these studies, isolated
lymphoid cells were stained for various membrane receptors with
FITC-, PE-, or biotin-labeled mAbs. Lymphoid cells were first
preincubated with an Fc-blocking mAb (clone 2.4G2; PharMin-
gen) at a concentration of 12.5 
 
m
 
g/ml for 5 min on ice. The cells
were then incubated with FITC-, PE-, or biotin-labeled anti-
bodies for 30 min in ice. Biotinylated antibodies were detected
with PE– or FITC–streptavidin. The following conjugated or
unconjugated anti–mouse antibodies were used: anti-CD3 (clone
145-2C11), anti-CD8 (clone 53.6.7), anti-B220 (clone RA3-
6B2), anti–TCR-
 
b
 
 (clone H57-597), anti–TCR-
 
g/d
 
 (clone
GL3), anti-IgD (11–26c.2a), anti-IgM (clone II/41), anti-IgA
(clone R5-140), and anti–I-A
 
d
 
 (clone AMS-32.1) (PharMingen).
Goat anti–IgG (Fab
 
9
 
) fragment was purchased from Southern
Biotechnology Associates. Two-color analysis was performed
with a FACStar
 
PLUS®
 
 (Becton Dickinson). In some experiments,
cells were stained
 
 
 
with FITC-labeled anti-CD4 mAb (clone
GK1.5; University of Alabama at Birmingham Core Facility) and
subjected to sorting with a FACStar
 
PLUS®
 
 to obtain purified
CD4
 
1
 
 T cells (
 
.
 
99% CD4
 
1
 
 T cells).
 
Culture Conditions and Proliferation Assays for T Cells.
 
For stim-
ulation of antigen-specific T cells, cells were coupled to TNBS.
In brief, cells isolated from patches, lymph nodes, or lamina pro-
pria were treated with 0.3 mg/ml TNBS in RPMI 1640 for 15
min at room temperature. Cells were then extensively washed
and cultured in RPMI 1640 supplemented with 10% FCS, so-
dium pyruvate, 
 
l
 
-glutamine, Hepes, 50 
 
m
 
M 2-ME, 100 U/ml
penicillin, 100 
 
m
 
g/ml streptomycin, 40 
 
m
 
g/ml gentamicin, and
1 
 
m
 
g/ml amphotericin B (complete medium) at 37
 
8
 
C in an at-
mosphere of 5% CO
 
2 
 
in
 
 
 
air. For the proliferation assay, 2 
 
3
 
 10
 
5
 
cells were placed in each well of 96-well plates, and 0.5 
 
m
 
Ci/well
of tritiated [
 
3
 
H]thymidine was added 18 h before harvesting.
Peyer’s, cecal, and colonic patch cells were incubated for 4 d, and
SLN cells were incubated for 3 d. The amount of [
 
3
 
H]thymidine
incorporation was determined by scintillation counting. Cells cul-
tured without TNBS treatment were used as controls. In some ex-
periments, TNBS-treated cells were cultured in complete medium
for 24 h at a concentration of 3 
 
3
 
 10
 
6 
 
cells/ml. Culture superna-
tants were subjected to cytokine-specific ELISA. For mRNA anal-
ysis, nonadherent cells were harvested after 24 h of incubation, and
CD4
 
1
 
 
 
T cells were purified by flow cytometry. Extracted total
 
RNA was subjected to RT-PCR to assess cytokine-specific
mRNA. The CD4
 
1
 
 
 
T cells purified from lamina propria lympho-
cytes isolated from the colon were subjected to RT-PCR.
 
Cytokine-specific ELISA.
 
The details of this assay have been
described previously (24–26). In brief, Immunoplates (Nunc
MaxiSorp; Nunc, Inc.) were coated with antibodies to individ-
ual cytokines and incubated overnight at 4
 
8
 
C. After blocking
with 3% BSA in PBS at 37
 
8
 
C for 2 h, diluted samples were
added to wells and incubated overnight at 4
 
8
 
C. The wells were
then washed and incubated with detecting antibodies, and bound
antibody was detected by peroxidase-labeled antibiotin mAb
(Vector Labs). 3,3
 
9
 
,5,5
 
9
 
-tetramethylbenzidine was used as a sub-
strate for peroxidase. The following anti-cytokine antibodies for
coating or biotinylated antibodies for detection, respectively,
were used in this ELISA: anti–IFN-
 
g
 
, R4-6A2 and XMG 1.2
mAbs; anti–IL-2, JES6-1A12 and JES6-5H4 mAbs; anti–IL-4,
BVD4-1D11 and BVD6-24G2 mAbs; anti–IL-5, TRFK-5 and
TRFK-4 mAbs; anti–IL-6, MP5-20F3 and MP5-32C11 mAbs;
and anti–IL-10, JES5-2A5 and JES5-16E3 mAbs. The ELISA as-
says were capable of detecting 0.02 ng/ml IFN-
 
g
 
, 0.05 U/ml
IL-2, 1.0 pg/ml IL-4, 0.1 U/ml IL-5, 0.1 ng/ml IL-6, and 0.04
ng/ml IL-10.
 
Cytokine-specific RT-PCR. Total RNA fractions were pre-
pared from antigen-stimulated CD41 T cells by the acid guadi-
nium–thiocyanate, phenol–chloroform extraction method (27).
Cytokine-specific RT-PCR was performed as previously de-
scribed in detail with minor modifications (28). In brief, a stan-
dard protocol was used for the RT reaction, and the resultant
DNA was amplified by repeating PCR for 35 cycles at 958C for
1 min and at 608C for 1 min.
Statistics. Statistical significance was determined by the Mann–
Whitney U test using the Statview-J 4.11 statistical program
(Abacus Concepts, Inc.) for Macintosh computers. To analyze
survival distributions, the Mantel–Cox test was performed, and
the significance level chosen was P 5 0.05.
Results
Wasting Disease in IFN-g1/1 and IFN-g–deficient Mice.
Previous studies have provided compelling evidence that
the Th1-type cytokine IFN-g plays a major role in experi-
mental IBD in mice. To examine the possible significance
of Th2-type responses, we first queried if colitis would de-
velop in mice deficient in IFN-g production. In these
studies, we found that weight loss, colitis, and even death
were dependent upon the dose of TNBS given, though the
differences in colitis-inducing versus lethal doses were small
in normal IFN-g1/1 mice. Interestingly, IFN-g2/2 mice
were more resistant to TNBS–ethanol enemas, with an ap-
proximate LD50 dose for IFN-g1/1 mice only causing the
death of 25% of IFN-g2/2 mice (Fig. 1 A). At the interme-
diate dose of 36 mg TNBS/g weight, .90% of mice in
both groups survived. In both groups, autopsy showed large
necrotizing ulcer rings and obstructed colons. With the low
dose of TNBS (25 mg/g of weight), all mice survived with-
out symptoms of colitis.
We used the intermediate dose of TNBS to compare
wasting disease in IFN-g2/2 and IFN-g1/1 mice (Fig. 1 B).
Administration of ethanol only had little effect on body
weight and produced no symptoms of colitis in mice of ei-1172 TNBS-induced Colitis in IFN-g–deficient Mice
ther group. On the other hand, the intermediate dose of
TNBS (36 mg/g) together with ethanol induced significant
weight loss and diarrhea in both mouse groups (Fig. 1 B).
Of interest was the finding that treatment of IFN-g1/1
mice with anti–IFN-g mAb did not prevent development
of wasting disease (Fig. 1 B). These findings show that al-
though IFN-g2/2 mice were more resistant than IFN-g1/1
mice to TNBS–ethanol enemas, they did develop signifi-
cant TNBS-induced wasting disease in the absence of IFN-g.
Histologic Characteristics of TNBS-induced Colitis in IFN-
g2/2 Mice. The pathological features of TNBS colitis
were essentially the same in IFN-g2/2 and IFN-g1/1 mice
given TNBS enemas of 36 mg/g. The entire colonic wall
became thick from edema. The major colitis lesion was ob-
served in the distal half of the colon, and focal ulcers were
detected in z70% of colonic tissues from either IFN-g2/2
or IFN-g1/1 mice. The ulcers often penetrated the colon
and adhered to adjacent tissues. Distortion of crypts, loss of
goblet cells, and infiltration of mononuclear cells were ob-
served in all mice, and most IFN-g2/2 mice showed these
changes in a more extended area of the colon than did
IFN-g1/1 mice. Some parts of the mucosal layer lost crypts
and were replaced with lymphocytes, macrophages, and fi-
brotic tissue (Fig. 2, B, C, E, and F). Crypt abscesses were
less frequent.
Another major finding in this model was an enlargement
of lymphoid follicles in the colon. The inflamed colon de-
veloped white patches that resembled Peyer’s patches in the
small intestine and protruded from the colonic wall into the
mesenteric side. When examined microscopically, these white
patches, which were distinct from other parts of the co-
lonic wall, were found to be lymphoid follicles (Fig. 2,
B and E). Before TNBS enema, the colonic lymphoid fol-
licles were difficult to detect macroscopically but were mi-
croscopically identified in tissue sections of both IFN-g2/2
and IFN-g1/1 mice (Fig. 2, A and D). When TNBS colitis
was induced, z7–8 white follicles per mouse were visible and
thicker than colonic follicles observed in mice before TNBS
enema (Table II). The cell yield from colonic patches was
dramatically increased after induction of colitis, and the
follicles in IFN-g2/2 mice contained higher numbers of
mononuclear cells than did the follicles in IFN-g1/1 mice
(Table II). This finding indicates that the enlargement of
these follicles in the inflamed colon was actually enhanced
by the absence of IFN-g.
Characterization of Colonic Follicles in TNBS Colitis. We
next investigated whether the follicles that appeared after
TNBS enema were secondary lymphoid aggregates or en-
larged GALT, e.g., Peyer’s patch–like structures. As IFN-
g2/2 mice developed larger follicles than control mice, we
Figure 1. The course of TNBS colitis in normal and IFN-g–deficient
mice. (A) Survival rate of mice given TNBS enema. IFN-g1/1 (left) or
IFN-g2/2 (right) mice were given 50 (j), 36 (d), or 25 mg TNBS/g
weight (s) intracolonically on days 0 and 7. Each group contained 16–18
mice. The survival rate after administration of 50 mg/g weight was signif-
icantly higher in IFN-g2/2 than in IFN-g1/1 mice. (B) Wasting disease
in mice given TNBS enema. Left, weight loss of IFN-g1/1 mice after ad-
ministration of ethanol only (h), 36 mg/g weight TNBS–ethanol (s),
TNBS–ethanol together with intraperitoneal administration of rat anti–
IFN-g antibody XMG1.2 (j), or rat IgG as a control (d) on days 0 and
7. Right, weight loss of IFN-g2/2 mice given TNBS–ethanol (d) or
ethanol only (u). The data shown represent average values, and each
group contained 5–10 mice. The weights of mice treated with ethanol
only were significantly higher than in other groups on days 1, 3, 5, and 10
(left) and on days 1, 3, 7, and 10 (right).
Figure 2. Histologic features of TNBS-induced colitis. (A–C) IFN-g1/1
mice; (D–F) IFN-g2/2 mice. A and D show normal colon with colonic
patches, and B, C, E, and F illustrate the colon after a TNBS enema.
Original magnification was 10 in A, B, D, and E and 40 in C and F.1173 Dohi et al.
considered it possible that there was a difference in lym-
phocytes between IFN-g2/2 and IFN-g1/1 mice that
could account for the severity of the disease. Immunohis-
tochemical analysis showed that these follicles had distinct
T cell areas and B cell zones with germinal centers (Fig. 3).
Flow cytometry analysis of mononuclear cells from these
follicles indicated that T cell subsets were similar to those of
Peyer’s patches in the small intestine and to cecal patches.
In IFN-g2/2 mice, CD41 T cells were significantly less fre-
quent in Peyer’s or cecal patches. Increases in macrophages
or other inflammatory cell types were not observed in
colonic patches. When compared with naive mice, both
IFN-g1/1 and IFN-g2/2 mice tended to show decreased
percentages of CD41 T cells (Table III). On the other
hand, the percentage of B cell subsets was slightly elevated
in both groups of mice after induction of colitis (Table IV).
Colonic follicles in IFN-g2/2 mice exhibited higher num-
bers of B cells when compared with either cecal or Peyer’s
patches. IFN-g2/2 mice had more surface IgA–positive B
cells than IFN-g1/1 mice. The higher percentages of B
cells noted in IFN-g2/2 when compared with IFN-g1/1
mice were also observed before induction of colitis. Col-
lectively, the colonic follicles of mice with TNBS colitis
showed a dramatic expansion of both T and B cells that
was accompanied by a relative increase in all B cell subsets.
M cells were identified in the epithelial cells covering the
follicles by electron microscopy. M cells exhibited irregular
microvilli with attached bacteria as well as interlaced mac-
rophages and lymphocytes that extended into the mito-
chondria- and vesicle-rich cytoplasm (Fig. 4). M cells were
Table II. Comparison of Lymphoid Follicles in the Colons of IFN-g1/1 and IFN-g2/2 Mice with TNBS-induced Colitis
TNBS enema
Mouse strain
IFN-g1/1 IFN-g2/2
Thickness of lymphoid follicles (mm)a 2 0.39 6 0.06* 0.37 6 0.05‡
1 0.55 6 0.17* 0.57 6 0.15‡
Cell yield from lymphoid folliclesb (106 cells/mouse) 2 1.7 6 0.62 0.7 6 0.20
1 4.55 6 1.13§ 6.37 6 1.90§
a10 patches were measured for each group. Values shown are the average 6 1 SD. *P , 0.02, ‡P , 0.05.
bValues shown are the average 6 1 SD from three to seven separate experiments using 5–7 mice/experiment. §P , 0.02.
Figure 3. Immunohistochemis-
try of colonic lymphoid follicles
of mice with TNBS colitis. The
distribution of T (red) and B
(green) cells in a colonic patch
from an IFN-g1/1 (A) or IFN-
g2/2 (C) mouse. Serial sections
were stained with PNA in B
(IFN-g1/1) and D (IFN-g2/2).
Original magnification was 100.1174 TNBS-induced Colitis in IFN-g–deficient Mice
found in follicles of both IFN-g2/2 and IFN-g1/1 mice.
From these studies, we conclude that the lymphoid follicles
induced by TNBS colitis are colonic patches that retain an
overall structure similar to that of Peyer’s patches of the
small intestine. The number of patches found in mice with
colitis was comparable to numbers reported in naive adult
BALB/c mice, as determined by an enumeration method
consisting of fixation and illumination of the colon (29),
leading us to conclude that these patches were not induced
de novo but were instead enlargements of existing patches
which became visible after TNBS enema.
Antigen-specific Proliferative Responses and Cytokine Profiles
of Colonic Patch Cells from Mice with TNBS Colitis. Antigen
(TNBS)-specific responses of colonic patch cells were ex-
amined. Mononuclear cells isolated from colonic patches
and SLN of mice with TNBS colitis responded to stimula-
tion with TNBS, whereas cells from Peyer’s or cecal patches
or colonic lamina propria did not undergo TNBS-specific
responses (Fig. 5 A). Cells from SLN of IFN-g2/2 mice had
lower proliferative responses than did those of IFN-g1/1
mice, perhaps due to the lack of response of cells normally
activated by the presence of IFN-g. These results show that
TNBS-responding cells are localized in the colonic patches
of both groups of mice.
Cytokine production accompanied by TNBS-stimulated
proliferative responses was also measured (Table V). Cells
from colonic patches and SLN of IFN-g1/1 mice produced
both IL-4 and IL-5 in addition to IFN-g and IL-2, and the
former also produced IL-6. Colonic patch and SLN cells
from IFN-g2/2 mice produced IL-4, IL-5, and IL-10. Secre-
tion of IL-5 by cells from IFN-g2/2 mice was higher than
that by cells from IFN-g1/1 mice, and this difference reached
statistical significance in cells from SLN. Although it has been
shown that Th2-type cytokine responses can be downregu-
lated by IFN-g (30), as much or more IL-4 was produced in
IFN-g1/1 mice as in IFN-g2/2 mice. Cytokine levels were
also assessed in culture supernatants of lamina propria lym-
phocytes; however, low levels were seen with or without
TNBS stimulation. These results indicate that Th2-type cyto-
kines were produced by colonic patch T cells in the inflamed
Table III. T Cell Composition of Colonic Lymphoid Follicles, Cecal Patches, and Peyer’s Patches from IFN-g1/1 and IFN-g2/2 Mice with 
TNBS Colitis
CD31 T cells
Colonic lymphoid follicles Cecal patches Peyer’s patches
IFN-g1/1 IFN-g2/2 IFN-g1/1 IFN-g2/2 IFN-g1/1 IFN-g2/2
CD42CD81 6.7 6 2.7 (4.5) 5.9 6 0.8 (2.0) 5.1 6 0.2 9.2 6 3.5 6.4 6 0.8 6.7 6 0.3
CD41CD82 19.7 6 3.8 (28.9) 18.8 6 2.4* (24.3) 26.4 6 2.3 31.9 6 4.9* 29.7 6 3.9 26.2 6 1.0*
CD41CD81 0.2 6 0.0 (0.56) 0.8 6 1.0 (0.83) 0.1 6 0.0 1.2 6 0.2 0.7 6 0.3 0.7 6 0.3
CD42CD82 1.3 6 1.7 (2.8) 0.7 6 0.1 (1.1) 2.6 6 1.3 1.8 6 0.9 1.2 6 0.5 1.0 6 0.6
a/b-TCR1 29.6 6 3.3 (26.0) 28.8 6 3.0 (23.2) 34.2 6 3.0 42.6 6 7.5 32.9 6 04.5 36.1 6 1.4
g/d-TCR1 0.5 6 0.1 (1.2) 0.8 6 0.1 (1.7) 0.5 6 0.1 0.5 6 0.0 0.7 6 0.2 0.8 6 0.2
Values shown are the average 6 1 SD of the percentage of mononuclear cells in three independently prepared cell fractions. Values shown in paren-
theses are for colonic lymphoid follicles from naive mice and were obtained from pooled cell fractions from 10 mice.
*P , 0.05.
Table IV. B Cell Composition of Colonic Lymphoid Follicles, Cecal Patches, and Peyer’s Patches from IFN-g1/1 and IFN-g2/2 Mice with 
TNBS Colitis
B2201 B cells
Colonic lymphoid follicles Cecal patches Peyer’s patches
IFN-g1/1 IFN-g2/2 IFN-g1/1 IFN-g2/2 IFN-g1/1 IFN-g2/2
Ig1 50.4 6 3.9 (32.9) 55.7 6 1.9* (50.7) 47.0 6 7.8 44.2 6 0.7 40.2 6 5.9 33.7 6 2.5*
I-Ad1 45.5 6 0.3 (23.4) 55.6 6 8.7 (47.1) 40.4 6 8.9 40.3 6 3.8 45.1 6 7.9 38.9 6 7.4
IgM1 40.1 6 5.1 (30.2) 55.7 6 2.5 (47.0) 33.5 6 9.9 31.0 6 3.6 35.2 6 0.9 27.9 6 1.6
IgA1 5.4 6 3.2* (6.5) 11.4 6 4.5* (10.1) 6.5 6 0.1 9.6 6 3.3 8.7 6 2.1* 13.9 6 1.1*
IgG1 2.3 6 0.2 (3.8) 2.2 6 0.2 (4.2) 2.4 6 0.2 1.1 6 0.5 1.6 6 0.2 1.9 6 0.7
IgD1 30.9 6 1.8 (18.3) 30.9 6 8.3 (30.5) 24.4 6 1.4 17.1 6 11.7 21.1 6 7.5 21.8 6 3.4
Values shown are the average 6 1 SD of percentage of mononuclear cells in three independently prepared cell fractions. Values shown in parenthe-
ses are for colonic lymphoid follicles from naive mice and were obtained from pooled cell fractions from 10 mice.
*P , 0.05.1175 Dohi et al.
colon and SLN obtained from both IFN-g1/1 and IFN-g2/2
mice. To confirm this, purified CD41 T cells were subjected
to analysis of cytokine-specific mRNA by RT-PCR (Fig.
5 B). The expression of mRNA from cytokines in TNBS-
specific CD41 T cells was similar to the results obtained for
secreted proteins. In addition, mRNA for IL-13, another
Th2-type cytokine, was also detected by RT-PCR.
In additional studies, we examined the time course of
mucosal cytokine responses in IFN-g1/1 and IFN-g2/2
mice. Lamina propria CD41 T cells were isolated on days
0, 1, and 10 and subjected to cytokine-specific RT-PCR.
On day 1, ulcers were present in the colon; however, the
colonic patches were poorly visible, and the size of SLN was
much smaller than that observed on day 10. In IFN-g1/1
mice, lamina propria CD41 T cells obtained on days 0, 1,
or 10 did not express IFN-g mRNA, although the total
lamina propria cell population contained IFN-g on days 1
and 10 (Fig. 6). Furthermore, freshly isolated CD41 T cells
taken from colonic patches or SLN on day 0, 1, or 10 also
failed to express mRNA for IFN-g. mRNA specific for IL-4
was detected in CD41 T cells from lamina propria on day
10 in both groups of mice (Fig. 6). When colonic lamina
propria CD41 T cells isolated from IFN-g1/1 or IFN-g2/2
mice were stimulated with anti-CD3 mAbs, mRNA for
both IL-4 and IL-5 was detected by RT-PCR (data not
shown). Thus, it was shown that both IFN-g1/1 and IFN-
g2/2 mice with TNBS colitis exhibit Th2-type cytokine
responses in colonic patches, SLN, and lamina propria.
TNBS Colitis in IL-4–deficient Mice. Our results to this
point have shown that Th2-type, rather than Th1-type cyto-
kines, are important in the lymphoid tissues of the inflamed
colonic site. We next studied TNBS colitis in the absence
of IL-4. Anti–IL-4 mAb treatment failed to prevent the
initial weight loss after TNBS enema in normal IL-41/1
mice. IL-42/2 mice given TNBS also suffered from severe
wasting disease and died within 3 d at the same rate (10%)
as untreated mice. However, the colitis in anti–IL-4 mAb-
treated or in IL-42/2 surviving mice was different from that
in IFN-g1/1 or IFN-g2/2 mice (Fig. 7). IFN-g2/2 mice
showed higher histologic scores than control mice. On the
other hand, IL-42/2 mice as well as normal mice treated with
anti–IL-4 mAb generally exhibited mild lesions, especially in
terms of deformation of crypts and chronic changes that re-
sulted in significantly lower histological scores.
Taken together, our present data indicate that Th2 cells
and the cytokine IL-4 play important roles in the induction
of crypt inflammation and hypertrophy of colonic patches in
the chronic phase of TNBS colitis induced in BALB/c mice.
Discussion
Two major new findings emerged from this study. Our
studies have provided the first evidence that TNBS colitis
develops in the absence of IFN-g in BALB/c mice. In ad-
dition, the TNBS colitis lesion is an enhanced expansion of
colonic patches where Th2-type cytokine responses are
prominent. The enlargement of colonic patches in TNBS
colitis was more evident in Th1-deficient IFN-g2/2 mice
than in IFN-g1/1 mice. These findings indicate that Th2-
type responses derived from colonic patches play a signifi-
cant role in TNBS colitis without a requirement for IFN-g.
Hypertrophy of patches in the inflamed colon appears to
be due to localized recurrent antigenic stimulation from lu-
minal TNP-haptenated antigens. Other GALT, e.g., cecal
and Peyer’s patches, did not respond to TNBS, suggesting
that colonic patch cells were responding to locally derived
Figure 4. M cells detected in a colonic lymphoid follicle of an IFN-g2/2
mouse after TNBS enema. Irregular microvilli with attached bacteria and
an underlying macrophage are shown. Bar, 5 mm.
Figure 5. TNBS-specific proliferative responses in IFN-g1/1 or IFN-g2/2
mice with TNBS colitis. (A) Proliferative responses of GALT and SLN cells.
Cells were prepared from small intestinal Peyer’s patches (white bar), cecal
patches (dotted bar), colonic lamina propria lymphocytes (gray bar), colonic
patches (black bar), and SLN (hatched bar). The stimulation index was de-
termined as cpm of wells with antigen (TNBS)/cpm of wells without
TNBS. The level of [3H]thymidine incorporation for control wells without
TNBS was ,600 cpm. Values are shown as the average ± 1 SD and are rep-
resentative of three separate experiments using pooled cells from 3–5 mice in
each group. (B) Expression of cytokine-specific mRNA in TNBS-stimu-
lated CD41 T cells. TNBS-stimulated total cell suspensions, which were
prepared from SLN or colonic patches (CP) from IFN-g1/1 (lane 1) or
IFN-g2/2 (lane 2) mice with TNBS colitis, were cultured for 24 h. CD41
T cells were purified by sorting and subjected to cytokine-specific RT-PCR.1176 TNBS-induced Colitis in IFN-g–deficient Mice
luminal antigens. Although the abundant presence of co-
lonic patches in humans has been well documented (31,
32), there are no studies reporting a direct relationship be-
tween IBD and colonic lymphoid tissues. However, we
would certainly expect that antigen uptake and processing
by colonic patches would be important during the process
of inflammation. In this regard, it has been reported that
the abnormal immune responses to intestinal flora that fol-
low a loss of tolerance may be one of the mechanisms for
IBD in humans (33, 34) and in mouse models (35, 36). Be-
cause colonic patches are more exposed to bacterial anti-
gens than are the Peyer’s patches of the small intestine, the
immunoregulatory functions of colonic patches as mucosal
inductive sites are important in the pathogenesis of IBD.
Recent clinical studies have shown different cytokine
profiles in Crohn’s disease and ulcerative colitis. In Crohn’s
disease, the production of IFN-g and the number of IFN-
g–producing cells were increased (18–20), whereas in ul-
cerative colitis, the increase was less pronounced. Lamina
propria CD41 T cells from Crohn’s disease patients showed
increased production of IFN-g after stimulation via the
CD28/CD2 accessory pathway, whereas cells from ulcer-
ative colitis patients showed enhanced production of IL-5
but not IFN-g (21). Furthermore, upregulation of IL-12 was
Table V. Cytokine Production by TNBS-stimulated Cells
Cells Mice
TNBS
enema
Stimulation
with TNBS
Th1-type cytokines Th2-type cytokines
IFN-g IL-2 IL-4 IL-5 IL-6 IL-10
ng/ml U/ml pg/ml U/ml ng/ml ng/ml
Colonic 
patches
IFN-g1/1
11 0.08 6 0.04 0.63 6 0.11 255 6 49 0.95 6 0.20 6.26 6 0.21* 0.05 6 0.00
12 , 0.05 0.10 6 0.01 24 6 16 0.17 6 0.14 ,0.1 ,0.04
22 , 0.05 0.10 ,5 0.10 ,0.1 ,0.04
IFN-g2/2
11 , 0.05 1.02 6 0.25 114 6 24 2.68 6 1.00 0.66 6 0.18* 0.32 6 0.25
12 , 0.05 0.42 6 0.25 5 6 4 0.47 6 0.34 0.55 6 0.08 ,0.04
22 , 0.05 ,0.05 5 0.65 ,0.1 0.1
IFN-g1/1
11 0.30 6 0.11 1.62 6 0.19 215 6 41 1.15 6 0.36* 0.25 6 0.03 0.20 6 0.13
12 0.06 6 0.04 0.58 6 0.25 ,5 ,0.1 0.01 6 0.01 0.17 6 0.00
SLN
22 0.07 ,0.05 ,5 ,0.1 ,0.1 ,0.04
11 , 0.05 1.43 6 0.11 174 6 14 3.38 6 0.42* 0.19 6 0.10 0.32 6 0.25
IFN-g2/2 12 , 0.05 0.31 6 0.25 2 6 2 0.46 6 0.23 0.11 6 0.10 ,0.04
22 , 0.05 ,0.05 ,5 ,0.1 ,0.1 ,0.04
Values shown are the average 6 1 SD of three independently prepared cell fractions. Values of mice without TNBS enema were obtained from a
pooled cell fraction taken from 10 mice. TNBS specific cytokine responses were not observed for IL-6 in IFN-g2/2 mice and for IL-10 in SLN of
IFN-g1/1 mice. In other studies, lamina propria lymphocytes from IFN-g2/2 and IFN-g1/1 mice were assessed for Th1 and Th2 cytokines and in
all instances, neither Th1- nor Th2-type cytokines were detected.
*P , 0.02. 
Figure 6. Expression of cy-
tokine-specific mRNA from
freshly isolated lamina propria
lymphocytes. Total colonic lam-
ina propria lymphocytes or
CD41 T cells purified by flow
cytometry were prepared on
days 0 (before TNBS enema), 1,
and 10 and subjected to cyto-
kine-specific RT-PCR. 50 ng of total RNA was used for each reaction.
Representative results from three individual experiments are shown.
Figure 7. Histological scores for Th1 and Th2 cytokine-deficient mice
with TNBS colitis. (A) IFN-g–deficient mice; (B) IL-4–deficient mice.
Each group included 4–10 mice. Values are shown as the average ± 1 SD.
The score of IFN-g2/2 mice was significantly higher than that of other
groups in A (P , 0.02). IL-42/2 mice and mice treated with anti–IL-4
mAb showed significantly lower values than did normal BALB/c and
IFN-g2/2 mice (P , 0.05). 2, rectal administration of ethanol only.1177 Dohi et al.
observed with Crohn’s disease but not with ulcerative colitis
(22). Thus, it is generally recognized that Th1-type T cells
are mainly involved in Crohn’s disease, whereas Th2-type
responses may have a more significant role in ulcerative coli-
tis. To this end, our findings support the notion that Th2-
type cells are involved in the development of an intestinal in-
flammation characterized by diffuse damage to the mucosal
layer that bears resemblance to ulcerative colitis.
A high dose of TNBS enema induced deep ulcers in the
acute phase of colitis that led to rapid weight loss and early
death in IFN-g1/1 mice. On the other hand, IFN-g2/2
mice were more resistant to this initial lethal phase of the
disease. These results suggest that IFN-g is important in the
acute phase of the disease. This notion was supported by
the presence of IFN-g in total lamina propria lymphocytes
from the early phase of disease in IFN-g1/1 mice (Fig. 6).
However, lack of mRNA for IFN-g in CD41 T cells indi-
cates that the production of IFN-g was likely induced in
other cell types that comprise innate immunity, rather than
by TNBS-specific Th1-type T cells in this experimental
system. Lesions observed in the later phase of colitis in-
duced by the intermediate dose of TNBS included distor-
tion of crypts, loss of goblet cells, and infiltration by mono-
nuclear cells. These lesions were frequently found to be
accompanied by a total loss of crypts with fibrosis and the
presence of a small number of granulomas. These morpho-
logical changes in crypts parallel those in ulcerative colitis.
Although both IFN-g1/1 and IFN-g2/2 mice showed
these crypt changes with Th2-type responses, the histologi-
cal score in IFN-g2/2 mice was somewhat higher than in
IFN-g1/1 mice (Fig. 7 A). Furthermore, IFN-g2/2 mice
developed larger colonic patches with higher numbers of B
cells than did IFN-g1/1 mice, which was due in part to in-
creased Th2-type responses. The lesions that resulted in all
of these mouse groups included enlargement of colonic
patches. These findings indicate that Th2-type responses
play an important role in chronic inflammation associated
with TNBS colitis. In this regard, we were unable to detect
mRNA for IFN-g in CD41 T cells isolated from the co-
lonic lamina propria throughout the course of disease;
however, we did detect mRNA for IL-4 on day 10. TNBS
colitis induced in SJL/J mice (14) or other models of colitis
(4, 10, 12) where Th1-type responses are predominant are
characterized by a dense cell infiltration with active de-
struction of all layers throughout the entire colon. In con-
trast, the inflammation that was induced in IFN-g1/1 or
IFN-g2/2 BALB/c mice on day 10 was characterized by
atrophic changes of the mucosal layer in the distal colon,
which occurred in the absence of extensive lymphocyte in-
filtration or destruction of tissue. Thus, histological features
in our model likely explain the lack of antigen-specific pro-
liferative responses and cytokine production by lamina pro-
pria lymphocytes. We postulate that this is a feature of
Th2-type inflammation in response to antigen that occurs
in the inductive site itself, e.g., the colonic patches where
constant stimulation of Th2-type cells disturbs the normal
tissue repair processes in lamina propria and regeneration of
epithelial cells, leading to fibrosis and the deformity seen in
crypts. Further support for this concept was offered by our
finding that IL-42/2 and normal BALB/c mice treated
with anti–IL-4 mAb developed an initial wasting disease
and severe ulcers but exhibited a milder lesion than did
control mice in the chronic phase of the disease.
Our study demonstrated that TNBS colitis in IFN-g1/1
mice was similar to Th2 cytokine-mediated colitis observed
in IFN-g2/2 mice. This is not surprising, as BALB/c mice
are known to favor Th2-type development of T cells,
whereas other mouse strains, such as B10.D2, favor Th1-
type development (37, 38). In this regard, the colonic patch
cells from IFN-g1/1 mice tended to produce larger amounts
of IL-4 and IL-6 when compared with identical cell fractions
taken from IFN-g2/2 mice. The low production of IL-6 in
cell cultures from IFN-g2/2 mice is most likely due to insuf-
ficient activation of macrophages in cultures lacking IFN-g.
We also consider the decreased IL-4 responses in IFN-g2/2
mice to be due to insufficient cell activation, as determined
by proliferation assays. These findings suggest that upregula-
tion of IL-4 production associated with TNBS colitis in
BALB/c mice may be independent of a cytokine regulatory
network involving IFN-g. Evidence for a Th2-type re-
sponse with colitis has been reported in TCR-a–deficient
mice, which develop spontaneous colitis. In these mice, cyto-
kine production by mesenteric lymph node cells showed a
marked increase in IL-4 synthesis (5). Furthermore, studies
have also shown that local CD41 TCR-a2/bdim1 T cells
were responsible for production of IL-4 (8). Recent studies
of hapten-induced colitis using oxazolone have also shown
that Th2-type cells can mediate intestinal inflammation (39).
Thus, it is possible that Th2-type responses are also involved
in other mouse models of IBD.
Previous studies by others have emphasized the major im-
portance of IFN-g production by Th1-type T cells in TNBS
colitis in a different mouse strain (SJL/J; 14). In contrast, our
study has now shown that TNBS colitis is associated with
Th2-type responses and with a pattern of inflammation that
resembles ulcerative colitis. Thus, the immune responses to
intracolonic TNBS can induce either Th1- or Th2-type re-
sponses, which are associated with distinct types of colitis.
The apparent differences in experimental conditions be-
tween our studies and those of others are in the mouse strain
and the dose of TNBS (14). However, luminal components
such as food antigens or intestinal microflora may also be in-
volved. These congenital and acquired factors could also
contribute to the differentiation of phenotypes of T cell re-
sponses and colonic inflammation. It is also clear that there
are clinical cases of IBD that are difficult to diagnose as either
Crohn’s disease or ulcerative colitis. Furthermore, the pheno-
type of disease can shift from one to the other during disease
progression. It is possible that environmental factors influ-
ence induction of Th1- or Th2-prone responses that reflect
distinct pathological features. Further investigation of the
phenotypic shift in TNBS colitis using normal and cytokine-
deficient mice will contribute to a better understanding of
the complex pathogenesis of IBD and may reveal the under-
lying immunologic differences that give rise to Crohn’s dis-
ease and ulcerative colitis.1178 TNBS-induced Colitis in IFN-g–deficient Mice
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